Integrating Quality, Risk, and EHS in the Life Sciences Industry

Article

Because of the industry’s close relation to consumer health and well-being, organizations competing in life sciences have a unique set of hurdles around quality, risk, and Environment, Health, and Safety (EH&S).

 

Because of the industry’s close relation to consumer health and well-being, organizations competing in life sciences have a unique set of hurdles around quality, risk, and Environment, Health, and Safety (EH&S). Many organizations today are faced with the challenge of disparate enterprise solutions and the resulting inability to communicate and collaborate on a unified information management system. This LNS Research Spotlight will help executives on the quality journey understand the framework for building this holistic quality platform, empowering them to strengthen their existing strategies. Get an overview of the life sciences industry as EtQ goes over benchmark data, the importance of building closed-loop quality processes and how to develop a unified information management system with Enterprise Quality Management Software.

 

Read more about integrating quality, risk, and EHS in the life sciences industry.

 

Contact:info@etq.com

Recent Videos
Related Content
Magnifying glass and check mark icon. Business concept,idea,right choice, quality control, approval and contract assignment | Image Credit: ©olyphotostories - stock.adobe.com

Qualifying Expertise for Quality Support

Felicity Thomas
April 4th 2025
Article

Bringing in external expertise may be necessary when internal knowledge is lacking, but it is critical that any contract employee or consultant is comprehensively assessed to ensure the right person is employed.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Nitrosamine Impurities inscription on wooden chips with stethoscopes on white background. Nitrosamine Impurities in certain drugs and pharmaceutical products concept. | Image credit: ©Debalina - stock.adobe.com

N-Nitrosamine Impurities and FDA’s Recommendations for Acceptable Intake Limits

Susan Haigney
April 4th 2025
Article

Josh Hoerner, general manager of Purisys, provides his perspective on FDA’s recommendations for acceptable intake limits for N-nitrosamine impurities.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption

INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption

Patrick Lavery;Feliza Mirasol
April 3rd 2025
Article

Sitting down with the PharmTech Group at INTERPHEX 2025, Nicole Hunter, head of Global WMArchitect at WMFTS, explains the industry initiative around single-use assembly components resulting from supply disruptions caused by the COVID-19 pandemic.

INTERPHEX 2025: Innovations in Advanced Sensing Technologies that Answer the Need for Reliable Valve Function

INTERPHEX 2025: Innovations in Advanced Sensing Technologies that Answer the Need for Reliable Valve Function

Patrick Lavery;Feliza Mirasol
April 3rd 2025
Article

Speaking with the PharmTech Group at INTERPHEX 2025, Dave Loula, global product director, ITT Engineered Valves, discusses innovation in advanced sensing technologies that addresses customer need for reliable valve function.